VERNON HILLS, Ill., June 1, 2017 /PRNewswire/ --áNexus Pharmaceuticals announced today the immediate availability in
About Nexus Pharmaceuticals Inc.
Nexus Pharmaceuticals (www.nexuspharma.net) is a U.S. based healthcare company that specializes in developing and marketing generic sterile injectable products. Through our high quality generic products, Nexus Pharmaceuticals is committed to providing patients with affordable prescription medicines that lower healthcare costs and provide a better quality of life. The company's headquarters is in Vernon Hills, Illinois.
Nitropress« is a registered trademark of Hospira Inc.
Media ContactNexus Pharmaceuticals Inc. Ayesha Ahmed[email protected]
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nexus-pharmaceuticals-receives-fda-approval-for-sodium-nitroprusside-injection-300467416.html
SOURCE Nexus Pharmaceuticals Inc.
Subscribe to our Free Newsletters!
Breathing in unclean air due to increasing air pollution could cause kidney damage with resultant ...
Benign prostatic hyperplasia or enlarged prostate is a noncancerous condition observed in men above ...
Urinary retention is a condition where a person is unable to voluntarily empty the urinary bladder ...View All